Press releases
Regulatory
April 26, 2022
Interim report January-March 2022
Regulatory
April 20, 2022
Egetis Therapeutics’ 2021 annual report published
Regulatory
February 17, 2022
Significant progress towards Emcitate® marketing applications in the US and Europe in 2023
Regulatory
November 4, 2021
Interim report January-September 2021
Regulatory
August 19, 2021
Emcitate development program progressing according to plan
Regulatory
April 22, 2021
Patient recruitment in the pivotal study with Emcitate progressing according to plan
Regulatory
March 30, 2021
Egetis Therapeutics 2020 annual report published
Regulatory
February 17, 2021
Egetis Therapeutics presents the fourth quarter and the year-end report 2020
Regulatory
November 11, 2020
Interim Report January 1-September 30, 2020
Regulatory
August 20, 2020
Calendar and upcoming reports
August 19, 2022
Half-year report January - June
August 24, 2022
Erik Penser Bank Bolagsdag
